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The murine major histocompatibility complex (MHC or H-2) x has been shown to 
control the in vitro generation of cytotoxic T-effector cells to trinitrophenyl-modified 
syngeneic  cells  (TNP-selt)  at  two  distinct  but  interacting  levels  (1-3).  First,  the 
cytotoxic effectors generated against TNP-self were shown to exhibit preferential lysis 
of targets matched with the responding and stimulating cells at the K or D regions of 
the MHC (4, 5). Second, the eytotoxic responses of spleen cells from mice expressing 
the k haplotype at the K  region and at part, or all, of the I region were found to be 
poor genetic responders to TNP-self at H-2D, irrespective of whether the haplotype 
at D  was d (B10.A)  (1, 2), b (B10.A[4R]), or k  (B10.BR)  (3, 6). Thus, for the T-cell- 
mediated lympholysis (CML)  responses, K  and  D  region products appear to affect 
the specificity of self recognition in association with TNP, whereas K  and  I  region 
products influence, at least in this system, the response potential (presumed to operate 
via immune response [Ir]  genes) for self-recognition of D-end-coded products. Other 
H-2 restricted viral-specific (7-12) and sex-linked antigen-specific (13) CML systems 
have been recently described in which H-2 products appear to be involved in Ir-gene 
control. 
Earlier studies indicated that Ir genes which control antibody responses could be 
most clearly demonstrated for complex multideterminant immunogens such as pro- 
teins  at  low  immunizing  doses  (14,  15).  Under  limiting  antigen  doses,  immune 
responses appeared to be triggered by only the more immunogenic determinants, and 
the Ir genes, controlling responses to those determinants, were detected in the absence 
of an immune response to other determinants (not under the control of the same Ir 
genes). It is known that the CML response to TNP-self by both mouse (4, 16, 17) and 
human  (18,  19)  leukocytes is complex, and  involves a  number of clones of effector 
cells.  Distinct  clones  have been  identified with  self specificity associated  with  the 
serologieally detectable MHC region products (4, 5,  18), with I region products (20, 
21), and with widely shared species-restricted self products  (18,  19).  In the present 
t Abbreviations used in this paper: CML, cell-mediated lympholysis; Ir, immune response; MHC, major 
histoeompatibility  complex; MSA, mouse serum albumin; PHA, phytohemaglutinin;  TNBS, trinltroben- 
zene sulfonate; TNP-, trinitrophenyl-. 
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study,  experiments  were  performed  using  mouse  spleen  cells  modified  with  lower 
concentrations oftrinitrobenzene sulfonate (TNBS) than commonly used to determine 
whether strain-dependent  differences in CML responses could be detected, and if so, 
whether  they would be linked  to the  H-2 complex.  This report  compares the CML 
responses of spleen cells from various mouse strains to syngeneic cells modified with 
low concentrations of TNBS, and discusses  the potential  relevance of Ir-gene effects 
and self recognition at low immunogen doses. 
Materials  and Methods 
Mice.  All  mice  used  were  males,  7-12  wks  old.  The  C3H/HeJ,  C3H.SW,  and  all  the 
C57BL/10 congenic mouse strains were purchased from The Jackson Laboratory, Bar Harbor, 
Maine. The BALB.K and BALB.B strains were kindly provided by Dr. D. H. Sachs, Immu- 
nology Branch, National Cancer Institute. The BALB/c and B 10.A (5R) strains were obtained 
from the Animal Production Unit, National Cancer Institute. 
Cell Cultures.  Mouse spleen cells  (7  ×  10  n) were cultured with 3  ×  106 irradiated  (2,000 
rads) TNBS-modified autologous spleen cells for 5 d as previously described (4, 22). Modification 
of stimulating, blocking, and target cells was performed by incubation of cells at 37°C for 10 
min,  as described  (4,  22),  with  various concentrations of TNBS  (0.05-10.0  mM)  diluted  in 
phosphate-buffered saline. 
Preparation  of TNP-conjugated bovine serum albumin and bovine gamma globulin, and 
the stimulation of spleen cell cultures with these TNP-conjugated proteins have been described 
in an earlier report (22). 
The  4-h  51Cr-release  assays  and  the  nonradiolabeled  cold  target  blocking  assays  were 
performed as reported elsewhere (4, 22). The target cells used were mouse spleen cells, stimulated 
48 h before assay with  1 #g/ml phytohemagglutinin PHA, except where otherwise indicated. 
The blocking cells used were freshly harvested mouse spleen cells. 
The percent iysis is calculated as previously described (22) and standard errors of the mean 
have been excluded from the table and the figures for simplicity, because they were usually 
<5%. 
Immunofluorescence and Flow Microfluorometry.  Fluoresceinated anti-TNP antibodies were pre- 
pared, B10.BR and C57BL/10 (B10) spleen cells were stained and fixed,  and flow microfluo- 
rometry was performed as described in a previous report (23) using a FACS II flow microfluo- 
rometer (Becton, Dickinson Electronics Laboratory, Mountain View, Calif.). 
Results 
Strain-dependent Differences of Cytotoxic Responses to Autologous Cells Modified with Low 
Concentrations of TNBS.  Spleen cells from B10.BR  (H-2  k)  and B10 (H-2  b)  mice were 
compared for their ability to generate cytotoxic responses to TNP-selfwhen stimulated 
in vitro with autologous spleen cells modified with different concentrations of TNBS 
(e.g., 10, 0.3, and 0.1 mM). The results of a representative experiment are summarized 
graphically  in  Fig.  1.  Strong  cytotoxic activity  was  observed  by  B10.BR  effectors, 
irrespective of the TNBS concentration used for modification.  At the effector:target 
cell  ratios  shown,  no differences  were  detected  in  lytic activity of B10.BR  effectors 
generated with  10, 0.3, or 0.1  mM TNBS modification. This is partly a  result of the 
fact that the effector cell titration curve is still on the plateau for B 10.BR in this range 
(see other figures).  In contrast to the B10.BR results,  lytic activity of B10 spleen cells 
was detected in cultures stimulated with TNP-self at  10 mM TNBS, but not at 0.3 or 
0.1 mM TNBS. Furthermore,  although comparable lysis was observed at an effector: 
target cell ratio of 40:1 for B 10.BR and B 10 effectors stimulated with  10 mM TNBS, 
B10 effector cell activity titered out more rapidly than  that of the B10.BR effectors. 
At least  fourfold more B10 than  B10.BR effectors were required  to obtain  50% lysis. GENE  M.  SHEARER  ET  AL.  1409 
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Fro.  1.  Cell-mediated cytotoxicity to TNP-selfat four effector:target cell ratios using B10.BR (A) 
or BI0  (B)  effector cells generated by sensitization with autologous spleen cells modified with  10 
mM  (H),  0.3  mM  (IK--~),  or  0.1  mM  (O----O)  TNBS,  or  with  unmodified 
(O---O)  autologous  cells.  Effectors were  assayed  on  syngeneic  PHA-stimulated  spleen  blasts 
modified with 10 mM TNBS. 
These results indicate that H-2-1inked strain-dependent differences exist between the 
B10.BR and BI0 effectors to TNP-self. 
To make a  more thorough comparison of the cytotoxic responses of B10.BR and 
B 10 spleen cells to TNP-self modified with different TNBS concentrations, B 10.BR- 
and  B10-stimulating  spleen  cells  were  modified  with  twofold  dilutions  of TNBS 
ranging from 2.0 to 0.031 mM, and added to cultures of B 10.BR- and B 10-responding 
cells, respectively. The lytic activity of the effectors generated was assayed on B 10.BR- 
TNBS and B10-TNBS targets modified with  I0 mM TNBS, and is summarized in 
Fig. 2. B10.BR effector cell activity was strong and about equal by stimulation in the 
range between 2.0 and 0.25 mM TNBS. A slight decrease was noted at 0.12 and 0.062 
mM, and still lower activity was detected at 0.031 mM, although stimulators treated 
with  all  concentrations of TNBS were immunogenic.  In contrast, B10 effector cell 
activity was much more dependent on the TNBS concentration used for stimulating 
cell  modification.  Modification  with  1.0  mM  TNBS  generated  effector  activity 
approximately equivalent to that observed with B 10.BR spleen cells stimulated with 
0.031  mM TNBS. For comparison, the effectors generated were also assayed on the 
respective TNBS-modified H-2 nonmatched targets. The results summarized in Fig. 
2 C  and 2 D  illustrate that the B 10.BR effectors lysed B 10-TNBS targets better than 
B10  effectors  lysed  B10.BR-TNBS  targets,  and  that  the  stimulatory  differences 
detected in these two strains on their respective modified H-2 matched targets are 
also reflected on modified H-2 unmatched target cells. 
Strain Differences  Are Independent of the Degree of TNP Conjugation of Individual Stimulating 
Cells.  The possibility exists that the differences observed in  the CTL responses of 
B10.BR and  B10 spleen cells could have resulted from the conjugation of different 
amounts of TNP to the cell-surface proteins of B10.BR and B10 spleen cells. To test 
this possibility, B 10.BR and B 10 spleen cells were modified with different concentra- 
tions  of TNBS,  and  then  incubated  with  affinity-purified  sheep  anti-TNP  IgG 
antibodies conjugated with fluoreseein isothiocyanate (23). The modified and stained 
cells were compared for their relative anti-TNP fluorescence intensity by flow micro- 
fluorometry using the FACS II flow microfluorometer (23). As summarized in Table 
I,  the  mean  fluorescence data  obtained  from  the  FACS  II  profiles  indicate  that 
quantitatively equivalent amounts of anti-TNP antibody were bound to the modified 
cells of the two strains for any given concentration of TNBS, which is consistent with 
equal  numbers of TNP groups conjugated to the cell surfaces of BI0.BR and  BI0 1410  H-2  CONTROL  OF  CYTOTOXICITY  TO  TRINITROPHENYL-SELF 
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F[o.  2.  Cell-mediated cytotoxicity to TNP-self at four effector:target cell ratios using BI0.BR (A, 
C) or B 10 (B, D) effector cells generated by sensitization with autologous spleen ceils modified with 
2  mM  (O-----4),  1  mM  (O--.--O),  0.5  mM  (O------O),  0.25  mM  (O----O),  0.125  mM 
(O  O), or 0.062  mM  (O--.--O)  or 0.031  (O-----O)  TNBS, or with unmodified  (O  ..... O) 
autologous cells.  Effectors were assayed on B10.BR  (A, D) or BI0 (B, C)  PHA-stimulated spleen 
blasts modified with 10 mM TNBS. 
spleen  cells.  Therefore,  the  differences observed between  the cytotoxic responses of 
B10.BR and B10 spleen cells to TNP-self using low concentrations of TNBS do not 
appear to be a  result of different amounts of TNP on the stimulating cells of these 
two strains, and can be attributed to some immunogenetic parameter(s). 
Strain Differences to Low Doses of TNP by Stimulation with  TNP-Conjugated Proteins or 
Low Dose TNBS-modified  Glass-Adherent Cells.  It has been previously shown that TNP- 
specific, H-2-restricted effector cells can be generated by stimulating cultures of mouse 
spleen  cells with  TNP-eonjugated  proteins  (22).  Such  stimulation  might  introduce 
limiting amounts of TNP in an immunogenic form on the cell surface, which could 
result in activation of B10.BR  but not B10 effector cell clones. Cultures  of B10.BR 
and B10 spleen cells were stimulated with  100 #g/ml of:  (a) TNP-conjugated bovine 
gamma globulin  (TNP-BGG);  (b) BGG;  (c) TNP-conjugated bovine serum albumin 
(TNP-BSA); or (d) BGG. B10.BR and B10 effector cell activity was assessed 5 d  later 
on  10  mM TNBS-modified H-2  k (RDM-4)  and H-2  b (EL-4)  tumor targets,  respec- 
tively. The results, illustrated  in Fig.  3, indicate that  B10.BR spleen cells generated 
cytotoxic activity when  stimulated  with  10  mM TNBS-modified syngeneic cells or 
with either TNP-BGG or TNP-BSA.  In contrast,  B10  spleen cells did not  generate 
eytotoxic activity above control  values  when  stimulated  with  TNP-BGG or TNP- 
BSA, although these spleen cells did generate a strong response when stimulated with 
syngeneic cells modified with  10 mM TNBS.  The absence of reactivity in  the  B10 
strain  to  100  #g/ml  of TNP-BGG or TNP-BSA  parallels  the  observation  that  the 
amount of TNP bound to the cell surface corresponds to a TNP modification of from 
0.1  to 1.0 mM TNBS (22). 
Glass-adherent  spleen cells modified with  10  mM TNBS have been shown  to be 
~10  times more efficient on a  per cell basis in  stimulating  the  generation  of TNP- GENE M.  SHEARER ET AL. 
TAHOE I 
Comparison of Quantitative FITC Anti- TNP Binding to TNBS-Modified 
BIO.BR and C57BL/ lO Spleen Cells as Measured by Flow 
Microfluorometry* 
TNBS concentration 
used to modify spleen 
cells 
Mean fluorescence:l:  of TNBS-modified spleen 
cells from 
BI0.BR  C57BL/10 
mM 
Unmodified  21  22 
1.0  3,756  4,024 
0.3  1,602  1,628 
0.1  1,200  1,148 
0.03  245  227 
* Determined by FACS II. 
Fluorescence values shown have been corrected for gain of 8,  and  are 
expressed in arbitrary units of fluorescence. 
1411 
specific  cytotoxic  effector cells  than  modifed  unfractionated  spleen  cells  (24).  To 
determine  whether  BI0  glass-adherent  cells  modified  with  low  concentrations  of 
TNBS  could stimulate  B10  responding cells more efficiently, unfractionated  spleen 
cells  from B10.BR  and  B10  donors were sensitized  in  vitro with  unfractionated  or 
glass-adherent syngeneic spleen cells modified with  10,  1.0, 0.1, or 0.01  mM TNBS. 
The effector ceils generated 5 d  later were assayed on//-2  ~ (RDM-4)  or H-2  ~ (EL-4) 
tumor target cells modified with  10 mM TNBS. The results are summarized in Fig. 
4.  B10.BR  spleen  cells responded  to syngeneic unfractionated  spleen cells modified 
with  any of these  four TNBS  concentrations,  and  to  glass-adherent  cells  modified 
with all but the lowest concentration of TNBS. In contrast, B 10 spleen cells responded 
to  unfractionated  syngeneic cells  modified  with  only  10  mM  TNBS  and  to  glass- 
adherent cells modified with  10 or  1.0 mM, but not those modified with 0.1  or 0.01 
mM TNBS. 
Strain Differences Can Be Demonstrated by Reducing the Stimulator Cell Number Modified at 
10  mM  TNBS.  The  results  presented  thus  far  have  not  established  whether  the 
differences between the cytotoxic responses of B10.BR and B 10 spleen cells would be 
reflected in the concentration of TNP groups on individual-modified stimulating cells 
or in the total amount of TNP added to the cultures.  Were the response differences 
dependent  on  the TNBS  concentration  on  individual  stimulating cells,  i.e.,  on  the 
extent of cell surface modification, cultures of B 10.BR and B 10 spleen cells should not 
exhibit the response differences that were observed in Figs.  1 and 2 when the cultures 
were  stimulated  with  different  numbers  of syngeneic  cells  modified  with  10  mM 
TNBS. The results of Fig. 5 illustrate that B 10.BR spleen cells respond better for any 
given number of syngeneic cells  modified with  10  mM TNBS  than  do B10  spleen 
cells. However, the results also indicate that titration of the total TNP concentration 
in the cultures by diluting out the cell number (at a  fixed concentration of TNP per 
cell) provides a more critical reduction in immunogenic dose for B10.BR-responding 
cells than  by reducing  the TNBS  (at a  constant  stimulator cell number)  (compare 
Figs.  5 and  2).  This could indicate that presentation of TNP groups on a  relatively 
large  number  of stimulating  cells  is  a  more  efficient  means  of stimulation  than 1412  H-2 CONTROL OF CYTOTOXICITY TO TRINITROPHENYL-SELF 
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Fla.  3.  Cell-mediated cytotoxicity to TNP-self at three effector:target cell ratios using B 10.BR (A) 
or BI0 (B) effector cells generated by sensitization with: autologous spleen cells modified with 10 
mM TNBS (0------0); 100 #g TNP-BGG (e  ~-- - --0); 100 p,g TNP-BSA (q~- - -O); or unmodified 
autologous  cells (O  ..... O).  Effectors were assayed on  syngeneic PHA-stimulated  spleen blasts 
modified with 10 mM TNBS. 
presentation  of the same  number of TNP  groups on a  lower number of stimulator 
cells. 
Demonstration of Strain Differences in  Target Cells Modified with Low Concentrations of 
TNBS.  The  results  presented  above  indicate  that  differences  between  the  CTL 
responses  of B10.BR  and  B10  cells  to  low  doses  of TNP-self can  be  demonstrated 
during sensitization,  i.e., at the responder and/or stimulator cell level. To determine 
whether  such  TNP  dose-dependent  differences  can  also  be detected  between  these 
two strains at the lytic phase,  B10.BR and B10 spleen cells were sensitized  to TNP- 
self modified with  10,  1.0, or 0.1  mM TNBS. The effectors generated were assayed 5 
d  later  on syngeneic PHA-stimulated  blast  targets  modified with  10,  1, or 0.1  mM 
TNBS at  an effector:target  cell  ratio  of 40:1  to detect  maximum  lysis.  The results, 
shown in Table II, indicate that B 10.BR effector-cell activity was generated to TNP- 
self at  10,  1, or 0.1 mM TNBS, and that the lytic activity could be detected on TNP- 
self targets modified with  10,  1, 0.1 mM TNBS. In contrast, B 10-effector cell activity 
was generated to TNP-self only at  10 mM. This lyric activity was detected on TNP- 
self targets modified with  10 and  1 mM TNBS, but not on TNP-self modified with 
0.1  mM TNBS.  These results suggest that  modification of B10 spleen cells with 0.1 
mM TNBS fails to form the necessary target antigen(s) or antigenic complex required 
for lysis by B 10 effectors. 
The above finding is confirmed and extended by the results of a similar experiment 
summarized  in Fig.  6, which is assayed on TNP-self and TNP-allogeneic  (for cross- 
reactive lysis) targets at several effector:target cell ratios.  B10.BR effectors generated 
by sensitization to TNP-self at 10, 1, or 0.1 mM TNBS lysed TNP-selftargets modified 
with  10,  1, or 0.1 mM TNBS. B10 effectors generated by sensitization  to TNP-self at 
10 or 1 mM TNBS lysed TNP-self targets modified with  10 or 1 mM TNBS, but not 
those modified with 0.1  mM TNBS.  Furthermore,  no B 10 effector activity could be 
detected  by  sensitization  with  0.1  mM  TNBS  and  assaying  on  TNP-self  targets 
modified with  10 or 1 mM TNBS. With respect to cross-reactive lysis, little or no lysis 
was detected on modified B10.BR targets by B 10 effectors except when both the B 10 
stimulators  and the B10.BR targets were modified with  10  mM TNBS.  B10 targets 
modified with  10 or 1 raM, but not 0.1 mM TNBS, were weakly lysed by BR effectors 
generated by sensitization of TNP-self treated with  10 or 1 mM but not with 0.1 mM 
TNBS.  These  results  indicate  that  B10  spleen  cells  do  not  generate  effectors when GENE  M.  SHEARER  ET AL.  1413 
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FIG. 4.  Cell-mediated cytotoxicity  to TNP-selfat four effeetor:target  cell ratios using BI0.BR (A, 
C) or B10 (B, D) effector cells generated by sensitization with autologous unfractionated spleen cells 
(3 X  10e/well) (A, B), or splenic glass-adherent  cells (0.3 ×  106/well) (C, D), modified with 10 mM 
(O----t),  1 mM  (O---.--O), 0.1  mM  (O------O),  or  0.01 mM  (0-----0) TNBS,  or  with 
unmodified autologous cells (O-----O). Effectors were assayed on RDM-4 (H-2 k) or EL-4 (H-2 b) 
lymphoid tumor target cells modified with 10 mM TNBS. 
stimulated with low doses of TNP-self which lyse B10.BR targets modified with low 
concentrations of TNBS, and that B 10.BR effectors generated with low doses of TNP- 
self do not lyse B10 targets modified with low concentrations of TNBS, despite the 
fact  that  the  low-dose  B10.BR  effectors  and  targets  are  adequate  for  detecting 
cytotoxic activity on modified self targets. 
The Strain Differences in Cytotoxic Response to Syngeneic Cells Modified with Low Concentra- 
tions of TNBS Are H-2 Linked. The observation that the congenic resistant B 10.BR and 
B 10 strains which share the B 10 background and differ only at H-2 were the respective 
responder and nonresponder to low concentrations of TNP was consistent with the 
differences being controlled by genes which are linked to the H-2 complex. To verify 
this, the cytotoxic responses to TNP-self by other congenic H-2  k and H-2  b strains on 
the C3H and BALB genetic backgrounds were compared. Irrespective of the non-H- 
2 background, spleen cells from H-2  k mice responded well to syngeneic cells modified 
with  10  or  0.1  mM  TNBS  (Fig.  7).  In  contrast,  cells  from  H-2  b mice  responded 
moderately to syngeneic cells modified with  10 mM, but not to those modified with 
0.1 mM TNBS. 
To provide more information on  the cytotoxic responses of other B10  congenic 
strains to low concentrations of TNP-self, spleen cells from B10.A and B 10.D2 mice 
were compared with those from B10.BR to syngeneic cells modified with  10,  1.0, or 1414  H-2  CONTROL  OF  CYTOTOXICITY TO  TRINITROPHENYL-SELF 
70 
60 
~_50 
>,40 
;~30 
20 
10 
0 
A 
.f  f  -m.,~  / 
/ 
/J 
...o-*-" 
?  ....  i  i  J 
10  20  40 
B 
[  i  i 
10  20  40 
EFFECTOR : TARGET CELL RATIO 
FIG.  5.  Cell-mediated cytotoxicity to TNP-self at four effector:target cell  ratios using B 10.BR  (A) 
or BI0 (B) effector cells  generated by sensitization with 3  x  10  6 (~-------~), 3  x  10  5 (0-- -  ---0), 
or  1  X  10  5 (0--  -0)  autologous spleen cells  all  modified with  10  mM TNBS, or with 3  X  10  6 
unmodified autologous spleen cells (O- - -O). Effectors were assayed on syngeneic PHA-stimulated 
spleen blasts modified with 10 mM TNBS. 
0.1  mM TNBS (Fig. 8). B 10.A spleen cells generated strong cytotoxic activity when 
stimulated  with  syngeneic cells  modified with  any  of the  three concentrations  of 
TNBS (similar to B 10.BR). B 10.D2 spleen cells generated moderate to strong responses 
to syngeneic cells modified with 10 or 1.0 mM TNBS, but only marginal responses to 
cells modified with 0.1  mM TNBS (similar to B10). Thus,//-2  k and/-/-2  ~ but not H- 
,4' and H-2  a strains appear to generate strong cytotoxic activity to low concentrations 
of TNP-self. 
The H-2 Associated Differences in Cytotoxic Response to Syngeneic Cells Modified with Low 
Concentrations of TNBS Are Expressed by  (BIO  ×  BIO.BR)F1  Responding and Stimulating 
Cells.  To determine whether the TNP dose-related differences between B 10.BR and 
B10  spleen  cells could  be  detected at  the  stimulator cell  level without  necessarily 
involving responding lymphocytes, (B 10 ×  B 10.BR)F1 responding cells were sensitized 
with B10, B10.BR, or (B10  ×  B10.BR )Fa stimulating cells modified with  10,  1.0, or 
0.1 mM TNBS. The effector cells generated were assayed 5 d later on 10 mM TNBS- 
modified, parental  or F1,  PHA-stimulated  target cells.  The results, summarized  in 
Fig. 9, indicate that Fl-responding cells do not respond better than BI0 cells to low 
doses of H-2  b TNP-self, irrespective of whether the modified stimulators or targets 
were of B10 or F1 origin (compare Fig. 9B, C, and E with Fig. 9A and B). The results 
of Fig. 9 F and G  indicate that the F1 behaves as a  responder when stimulated with 
low doses of TNBS-modified H-2  k parental cells and assayed on TNBS-modified F1 or 
H-2  k parental targets. The results of Fig. 9 H  and I indicate the levels of TNP cross- 
reactive lysis detected by B10.BR and B10 effectors generated by sensitization to 0.1 
mM TNP-self. 
Discussion 
The present study demonstrates the existence of H-2-1inked genetic differences in 
the ability of mouse spleen cells to generate cytotoxic effector cell activity specific for 
TNP-self targets, by limiting the amount of TNBS used to modify the stimulating or 
target cells or by using limiting numbers of TNP-self stimulator cells. H-2  a and H-2  k 
strains  are  high  responders  to  TNP-self,  whereas  H-2  b  and  H-2  a  strains  are  low 
responders;  (H-~'  ×  H-2k)F1  mice  are  high  responders  to  H-2k-TNP  but  lower 
responders to H-2b-TNP. The observed genetic differences in responses to TNP-self 
could result from a relative defect in the low responder strains during the sensitization GENE M.  SHEARER ET AL. 
TABLE II 
Comparison of Cytotoxic Activity Generated by BIO.BR and C57BL/ lO 
Spleen Cells Stimulated with TNP-Self Modified with 10,  1, or 0.1 mM 
TNBS, and Assayed on TNP-Self Targets Modified with I0,  1, or O. 1 mM 
TNBS 
Concentration of 
Responding-,  TNBS used to 
stimulating-, and  modify stimulating 
target-cell strain  cells 
B10.BR 
C57BL/10 
Lysis on synergic target cell mod- 
ified with TNBS at: 
I0 mM  1 mM  0.1 mM 
%  %  % 
10  mM  77.5  87.5  55.9 
1  mM  76.3  91.9  61.2 
0.1 mM  59.8  100.0  48.0 
---  10.1  0.7  -2.8 
10  mM  48.4  26.8  -6.0 
1  mM  5.5  0.1  -9.3 
0.1 mM  -10.7  -15.6  -9.3 
....  5.6  -15.3  -9.3 
Effector cell activity was assayed at effector:target 
PHA-stimulated syngeneic spleen blasts. 
cell ratio of 40:1  on 48-h 
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phase (involving the responder, stimulator, helper, or presenting cells) or during the 
lytic phase of the response (involving the effector or target cells). Defects expressed at 
the stimulator and/or target cell levels could conceivably be a result of the failure of 
cells  from  low  responder  mice  modified  with  limiting  doses  of TNBS  to  form 
immunogenic  self-TNP  complexes.  Such  would  be  the  case  if low  doses  of TNP 
specifically failed  to  modify the  relevant  low  responder haplotype  H-2  structures 
required  for self recognition either because low responder cells were generally less 
susceptible to modification by TNP or because low responder cells expressed fewer 
self-recognition  determinants  than  high  responder  cells.  Alternatively,  the  defect 
might  result  from  an  inability  of low  responder cells  to  respond  to  competently 
presented TNP-modified self antigens.  This might result from decreased affinity or 
decreased frequency of self-TNP specific cytotoxic precursor cells in  low responder 
strains,  or could  result  from a  generally lower cytotoxic activity of low  responder 
effector clones. 
The microfluorometry data shown in Table I  indicate that  the observed genetic 
differences are  not  a  result  of detectable  differences in  the  total  amount  of TNP 
conjugated  to  the  surfaces  of B10  and  B10.BR  spleen  cells  at  any  given  TNBS 
concentration. Furthermore, the fact that these strain-dependent differences could be 
observed by varying the total amount of TNP in the culture, either by sensitizing the 
responding cells by using a constant number of stimulator cells modified with varying 
concentrations of TNBS or by using a constant relatively high concentration of TNBS 
(10 raM) for modification and varying the stimulator cell number, indicates that the 
density of TNP group per cells in the range studied was not the only important factor. 
A  10-fold decrease in  the TNBS concentration used  for modifying the stimulating 
cells resulted in a more drastic reduction in the level of CTL generated than a  10-fold 
dilution in the number of stimulating cells (modified with 10 mM TNBS). However, 
this  result  does  not  exclude  the  possibility  that  fewer  relevant  determinants  are 
modified  on  H-2  b  than  on  H-2  k  cells.  Nevertheless,  the  finding  that  the  strain- 1416  H-2  CONTROL  OF CYTOTOXICITY  TO TRINITROPHENYL-SELF 
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Fzo. 6.  Cell-mediated eytotoxiclty to TNP-self at six effector:target eel| ratios using B 10.BR (A, B, 
C, J, K, L) or B 10 (D, E, F, G, H, I) effector cells generated by sensitization with autologous spleen 
cells modified with  10 mM (l~"-----~), 1 mM (O--.~D), or 0.1 mM (0---0)  TNBS, or with 
unmodified (O- - -O) autologous cells. Effectors were assayed on B10.BR (A, B, (2, D, E, F) or B10 
(G, H, I, J, K, L) PHA-stimulated spleen blasts modified with 10 mM (A, D, G, J), 1 mM (B, E, H, 
K), or 0.1 mM (C, F, I, L) TNBS.  (/) indicates the effectors/targets-molarity  of TNBS  used for 
target modification. 
dependent  differences can be detected by using a  lower number of stimulating cells 
modified with a  fixed concentration of TNBS  is consistent with the density of TNP 
molecules on the cell surface being less limiting than some other determinant  in the 
low responder haplotype. It is not known whether there are quantitative differences 
in the amount of H-2 molecules relevant for recognition by CTL per cell on H-2  b and 
H-2  k spleen cells. If no overall difference exists, it is still possible that self recognition 
structures relevant for TNP  recognition constitute a  minor component of the total K 
and D  antigens. These components could differ significantly in H-2  b and H-2  k mice. 
It should be noted that Forman and eoworkers (25-28)  have made an extensive study 
of the  amount  of TNP  conjugated  to  cell-surface proteins  as  a  function  of TNBS 
concentrations.  Their  investigations  indicated  that  a  direct  correlation  could  be 
demonstrated  between  the  ability  of modified  syngeneic  murine  cells  to  serve  as 
stimulators  or  targets  in  the  H-2-restricted TNP-specific  CML  and  the  degree  of 
conjugation of TNP  groups to H-2 antigens (26). GENE  M.  SHEARER  ET  AL.  1417 
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F~o.  7.  Cell-mediated cytotoxicity to TNP-self at three effector:target cell ratios using C3H/HeN 
(A), C3H.SW  (B),  BALB.K  (C),  or  BALB.B  (D)  effeetor cells generated  by sensitization with 
autologous spleen cells modified with  10  mM  (qg----O)  or 0,1  mM  (0---0)  TNBS,  or with 
unmodified (O- -  -O) autologous cells. Effectors were assayed on C3H/HeN  (A, C) or DBA/2 (B, 
D). 
Our results indicate that a defect in H-2  b spleen cells can be detected by lowering 
the TNBS concentration used to modify the target cells.//-2  ~ but not H-2  ~ effector 
cells activated by  10 mM TNP-self lysed 0.1  mM TNBS-modified syngeneic target 
cells, which demonstrates a  target cell defect, or an inability of H-2  b lymphocytes to 
react  with  syngeneic stimulator or target  cells modified with  0.1  mM  TNBS.  The 
results obtained with cross-reactive lysis on TNBS-modified H-2-nonmatched targets 
are also compatible with a defect at the target cell level which could be independent 
of effector cell generation, because B 10.BR effectors lysed B 10.BR but not B 10 targets 
modified with low concentrations of TNBS.  However, the TNP cross-reactive data 
also suggest that a  defect probably exists at the responding and/or stimulating cell 
level, because B 10 effectors generated by stimulation with low doses of TNP-self did 
not lyse B 10.BR targets modified with 10 mM TNBS, although the same targets were 
lysed by BR effectors generated with low doses of TNP-self. If a defect exists in H-2  b- 
stimulating cells, it is not reversed by using the most potent stimulating cell population 
known  (24), because the  use of TNBS-modified, splenic-adherent  stimulating  cells 
resulted  in  the same  genetic differences observed when  unfractionated spleen cells 
were used as stimulators. 
/r-like genetic effects have been demonstrated  for H-2-restricted (1-3)  and cross- 
reactive (21,  29)  cytotoxic responses to TNP-self, as well as for restricted cytotoxic 
responses  to  virus-infected cells  (7-12)  and  cells  expressing  the  HY  antigen  (13). 
Responses  of (B10  ×  B10.BR)F1  spleen  cells stimulated  by B10.BR-,  B10-, or F1- 
stimulating  cells  modified with  low concentrations of TNBS  were  investigated  by 1418  H-2  CONTROL  OF  CYTOTOXICITY  TO  TRINITROPHENYL-SELF 
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FiG.  8.  Cell-mediated  cytotoxicity  to  TNP-self at  three  effector:target  cell  ratios  using  BI0.BR 
(A), BI0.A (B), or B10.D2  (C) effector cells generated by sensitization with autologous spleen cells 
modified with 10 mM (e~"-4),  1 mM (q~--. ~),  or 0.1 mm (O- -  -0) TNBS, or with unmodified 
(O---O)  autologous  cells.  Effeetors  were  assayed  on  syngeneic  PHA-stimulated  spleen  blasts 
modified with  10 mM TNBS. 
comparing the cytotoxic activity of H-2 k, H-2 b and (H-2 b ×  H-2k)F1  spleen cells and 
that of Fa-responding cells sensitized with modified parental or Fl-stimulating cells to 
determine whether introduction of:  (a)  the H-2  k haplotype would increase  response 
potential to low doses of TNP-H-2 b, or (b) the H-2  b haplotype would decrease response 
potential to low doses of TNP-H-2 k. The results indicate that F1 spleen cells were not 
better  responders  to H-2b-stimulating  cells  modified  with  low doses  of TNBS  than 
were  the unresponsive H-2b-parental-responding cells,  although the same pool of F1 
cells  generated  strong cytotoxie activity  when stimulated  with  low doses  of TNBS- 
modified  H-2  ~ cells.  Consequently,  if a  responding  cell  defect  exists,  these  results 
demonstrate that neither introduction of the H-2  k haplotype nor differentiation in the 
F1 thymus results  in correction of nonresponsiveness to low doses of H-2b-TNP-self. 
This is similar to the/r gene-controlled antibody response to (T, G)-A--L, in which F1 
T  cells can initiate a response through interaction with responder accessory cells, but 
not by interaction with nonresponder accessory cells  (30). Because the present study 
does not clearly demonstrate a responding cell defect, we cannot address the question 
of whether  such  a  defect  would be  expressed  as  differences  in:  (a)  responding cell 
frequency;  (b) affinity of responding cells; or (c) cytotoxic activity ofeffectors from H- 
2 b and H-2  k mice. However, the observation that Fl-responding cells generated strong 
cytotoxie activity to low doses of H-2k-TNP-self but not to H-2b-TNP-self indicates 
that the differences  in the reactivity between B10.BR  and B10 cells was not a result 
of nonspecific,  generally  lower response potential  to low doses of TNP-self,  because 
low responsiveness was haplotype-specific in the F~. 
It  is  noteworthy  that  the  cross'reactive  lysis  detected  by  effeetors  generated  by 
TNP-self and assayed on TNP-modified  allogeneic  targets was  lower in magnitude 
but  similar  in  pattern  to  that  observed  for different  doses  of TNP-self  assayed  on 
modified  self targets.  The  finding that  cross-reactive  lysis was  stronger  for BI0.BR 
than for B10 effectors contrasts with those of Billings et al.  (21, 29) who found that 
spleen cells from B10.BR and BI0 mice were the respective low and high responders 
in cross-reactive lysis to TNP. The reasons for the differences between our results and 
those of Billings et al. are not known. 
Earlier studies have shown that the in vitro generation of cytotoxic effector cells to _J 
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FIo. 9.  Cell-mediated cytotoxicity to TNP-self at three effector:target  cell ratios using B I0.BR, 
BI0, or (B10 ×  B10.BR)Fx effector cells generated  by sensitization of F1 or parental spleen cells 
modified with 10 mM (0----"0), 1 mM (O--.--O), or 0.1 mM (0- - -0) TNBS. The lytic values 
from cultures sensitized with unmodified cells were <2% on all targets assayed in this experiment, 
and have been omitted from the graphs. Effectors were assayed on Fl or parental PHA-stimulated 
spleen blasts modified with 10 mM TNBS.  (Responders/Stimulators/Targets)  for each graph are 
indicated as follows: A, (BI0/B10-TNP/B10-TNP);  B, (Fa/B10-TNP/BI0-TNP);  C, (F1/F]-TNP/ 
B 10-TNP); D, (B 10/B 10-TNP/Fa-TNP);  E, F~/B 10-TNP/FrTNP); F, (F1/B 10.BR-TNP/F~-TNP); 
G,  (BI0.BR/B10.BR-TNP/BI0.BR-TNP);  H,  (B10.BR/BI0.BR-TNP/B10-TNP);  I,  (BI0/B10- 
TNP/B 10.BR-TNP). 
1419 
TNP-self is associated with a  loss in ability of the cultures to generate TNP-specific 
plaque-forming cells (PFC)  (31). This could be a  result of suppression of the antibody 
response  either  by  cytotoxic  effectors  themselves  or  by  a  separate  population  of 
suppressor cells generated concomitantly with the effectors. Because spleen cells from 
B10.BR  or B10.A,  but  not  from  B10  mice, generate  cytotoxic responses  to limiting 
doses of TNP-self (including cultures stimulated with  TNP-conjugated  proteins), it 
might be predicted that H-2  b mice would be higher genetic responders than//-2 k or 
H-2  b/k mice for TNP-specific antibody responses to TNP presented in association with 
antigens. Consistent with this prediction is the observation that B 10.D2 and B 10 mice 
were reported to be respective high  and  intermediate antibody responders to TNP- 
conjugated mouse serum albumin (MSA), whereas B 10.A and (B 10.A  ×  B 10)F1 mice 
were  low  responders  (32).  This  raises  the  possibility that  the  H-2-1inked  lack  of 1420  H-2 CONTROL OF CYTOTOXICITY TO TRINITROPHENYL-SELF 
antibody response to TNP-MSA in FI mice is associated with the ability of the H-2  ~ 
haplotype to respond well in CML to low doses of TNP-self. From the results of Fig. 
9 and (30) we would predict that F1 T-helper and B-precursor cells would be high or 
intermediate  antibody  responders  to  TNP-MSA  when  accessory  cell  function  is 
provided by the//-2  a or H-2  b parental haplotype. 
The TNP-dose-dependent differences observed in the present study could be TNP- 
specific, i.e., they could be specific for the modifying hapten or infectious agent, or 
these results could imply the existence of a  general  H-2-1inked response pattern to 
limiting antigen doses which would be H-2 self specific and not determined by the 
particular  antigen  recognized  in  association  with  self.  It  should  be  noted  in  this 
context that  H-2-restricted cytotoxic responses to limiting doses of virus appear in 
preliminary experiments to exhibit a similar strain-dependent pattern (W. E. Biddison 
and G. M.  Shearer, unpublished observations). This also agrees in general with the 
H-2-restricted  CTL  (33)  and  skin  graft  (34)  results  to  the  HY  antigen  in  which 
responses involving//-2  k appear to be stronger than  those involving//-2  b or//-2  a. 
Our observation that the genetic differences between B10 and B10.BR mice could be 
detected by lowering the stimulating cell number (modified with an excess of 10 mM 
TNBS) suggests that a component other than TNP is limiting. That component could 
be H-2  b and H-2  a self-recognition determinants. It is possible that the self-recognition 
determinant coded for by H-2K* genes provides an unusually efficient structure for 
CTL, and thereby represents the exception rather than the examples shown for//-2  a 
and H-2  b. Preferential recognition of K ~ self determinants over D b and D a have been 
reported in viral (9-11) and TNP (1-3) CML studies, and the responses demonstrated 
to low doses of TNP-self in H-2* and/-/-2  ~ mice may reflect immunodominance of H- 
2K* (9). 
The  present  study  demonstrates  that  TNP-specific  H-2-restricted  eytotoxic re- 
sponses are controlled by H-2-1inked genes, the effects of which can be clearly detected 
only when the responding cells are exposed to relatively low concentrations of TNP. 
Although TNP is not an infectious or pathogenic agent, the ease with which different 
amounts of this hapten can be conjugated to cell surfaces makes the system potentially 
useful as a model for investigating H-2-restricted viral systems. The possibility exists 
that  similar  MHC-linked  genetic effects which  are  not  detected at  relatively high 
doses of immunogen may be demonstrable at lower immunogen doses for other MHC- 
restricted CTL systems such as viruses. Antigen dose-dependent genetic regulation by 
the  MHC  could  be  critical  for  initiating  T-cell  immune  reactivity  after  chronic 
infections. 
Summary 
Spleen  cells  from  B10.BR  and  C57BL/10  (B10)  mice were  compared  for their 
ability to generate primary in  vitro cytotoxic responses to syngeneic cells modified 
with  different concentrations  (from  10  to 0.031  mM)  of trinitrobenzene sulfonate 
(TNBS) (TNP-self). Although both strains generated effector cells to TNP-self in the 
range of 10-0.25 mM TNBS modification, effector activity of B10 cells was weaker 
than that of B10.BR cells. BI0 spleen cells did not respond to syngeneie stimulating 
cells modified at 0.1  mM or lower, whereas B10.BR cells generated effector activity 
even  when  stimulated  by  TNP-self modified  with  as  low  as  0.031  mM  TNBS. 
Fluorescence analysis of the modified cells using the FACS II indicated that equivalent GENE M.  SHEARER ET AL.  1421 
quantities of TNP were conjugated to the surfaces of B 10.BR and B 10 spleen cells for 
any given concentration of TNBS modification. Similar strain-dependent differences 
were observed when the TNP was diluted out in the cultures by reducing the number 
of stimulating  cells  modified  with  10  mM  TNBS.  These  response  patterns  were 
verified by stimulating  cultures  of BI0.BR  and  B10  spleen  cells either with TNP 
conjugated to bovine serum albumin  or bovine gamma  globulin  (B10.BR but  not 
B10  cells  responded  to  TNP-conjugated  proteins)  or  with  TNBS-modified  glass- 
adherent spleen cells. The strain-dependent differences could also be detected at the 
effector phase, because optimally stimulated B 10.BR, but not B 10 effector cells, could 
lyse 0.1 mM TNBS-modified syngeneic target cells. The genetic parameters associated 
with the response and nonresponse patterns of B10.BR and B10 mice were further 
investigated by comparing the cytotoxic responses to low doses of TNP-self of spleen 
cells from the following strains: (a) C3H/HeJ (H-2  k) and C3H.SW (H-2b); (b) BALB.K 
(H-2  ~) and BALB.B (H-2b); and (c) B10.A (H-2  a) and BI0.D2 (H-2a). The H-2  k and 
H-2  ~, but not the H-2  ~ and H-2  a, strains generated cytotoxic responses to TNP-self 
when the syngeneic stimulators were modified with 0.1  mM TNBS. Further studies 
using  (B10  ×  B10.BR)F1 responding cells and parental or Fl-modified stimulating 
cells, indicated that the F1 cells generated cytotoxic activity to low doses of TNP in 
association with H-2  ~ but not in association with H-2  b self products. The results of 
this study indicate that H-2-1inked genetic factors, expressed in the target as well as 
in the responding and/or stimulating cell populations, control the ability of inbred 
mouse strains to generate cytotoxic effector cells to low doses of TNP-self. Such dose- 
dependent genetic effects may be important in the regulation of immune responses 
activated in vivo by chronic exposure to infectious agents. 
The  authors  express  their  gratitude  to  Dr.  Pierre  Henkart  for providing the  fluorescein- 
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manuscript. 
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